StockData
Strata Critical Medical, Inc. logo

Strata Critical Medical, Inc. (SRTA) stock

SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)

Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –

Earnings

Strata Critical Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 2, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$74.10M
+50.3% on a year earlier
EPS, Q3 FY2026
-$0.09
Latest guidance
Issued
Nov 3, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Strata Critical Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 2, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026before the open$74.10M+50.3%-$0.09Release
Q2 FY2026ended Jun 30, 2026Aug 4, 2026before the open$72.50M––Release
Q1 FY2026ended Mar 31, 2026May 6, 2026before the open$67.40M+24.1%$0.03Release
Q4 FY2025ended Dec 31, 2025Mar 3, 2026before the open$66.79M+22.8%–Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025before the open$49.30M-34.2%–Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open–––Release
Q1 FY2025ended Mar 31, 2025May 12, 2025before the open$54.30M+5.4%–Release
Q4 FY2024ended Dec 31, 2024Mar 13, 2025before the open$54.40M+14.5%–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$74.90M+4.9%–Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024after the close$67.90M+11.3%-$0.15Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$51.50M+13.7%-$0.06Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Strata Critical Medical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueGAAPFY2026$285.00M – $295.00M–NewNov 3, 2026
RevenueFY2026$285.00M – $295.00M$260.00M – $275.00MRaisedAug 4, 2026
RevenueGAAPFY2026$260.00M – $275.00M–NewMay 6, 2026
Adjusted EBITDAnon-GAAPFY2026$33.00M – $35.00M–NewNov 3, 2026
Adjusted EBITDAnon-GAAPFY2026$33.00M – $35.00M$29.00M – $33.00MRaisedAug 4, 2026
Free cash flow, before aircraft and engine acquisitionsnon-GAAPFY2026$15.00M – $22.00M–NewNov 3, 2026
Free cash flow, before aircraft and engine acquisitionsnon-GAAPFY2026$15.00M – $22.00M$15.00M – $22.00MReaffirmedAug 4, 2026

Guidance history

Every forecast Strata Critical Medical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 3, 2026Adjusted EBITDAFY2026$33.00M – $35.00MNew
Nov 3, 2026Free cash flow, before aircraft and engine acquisitionsFY2026$15.00M – $22.00MNew
Nov 3, 2026RevenueFY2026$285.00M – $295.00MNew
Aug 4, 2026Adjusted EBITDAFY2026$33.00M – $35.00MRaised
Aug 4, 2026Free cash flow, before aircraft and engine acquisitionsFY2026$15.00M – $22.00MReaffirmed
Aug 4, 2026RevenueFY2026$285.00M – $295.00MRaised
May 6, 2026Adjusted EBITDAFY2026$29.00M – $33.00MReaffirmed
May 6, 2026Free cash flow, before aircraft and engine acquisitionsFY2026$15.00M – $22.00MReaffirmed
May 6, 2026RevenueFY2026$260.00M – $275.00MNew
Mar 3, 2026Adjusted EBITDAFY2026$29.00M – $33.00MNew
Mar 3, 2026Free cash flow, before aircraft and engine acquisitionsFY2026$15.00M – $22.00MNew
Mar 3, 2026RevenueFY2026$260.00M – $275.00MNew
Nov 10, 2025Adjusted EBITDAFY2025$13.00M – $14.00MNew
Nov 10, 2025RevenueFY2025$185.00M – $195.00MNew
Aug 5, 2025RevenueFY2025$245.00M – $265.00MReaffirmed
May 12, 2025RevenueFY2025$245.00M – $265.00MReaffirmed
Mar 13, 2025RevenueFY2025$245.00M – $265.00MRaised
Nov 12, 2024Passenger revenueFY2025$85.00M – $95.00MNew
Nov 12, 2024RevenueFY2024$240.00M – $250.00MReaffirmed
Aug 7, 2024RevenueFY2024$240.00M – $250.00MReaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Strata Critical Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. Strata Critical Medical Announces Third Quarter 2026 Results
    Results
  2. Strata Critical Medical Announces Second Quarter 2026 Results
    Results
  3. Strata Critical Medical Announces First Quarter 2026 Results
    Results
  4. Strata Critical Medical Announces Fourth Quarter 2025 Results
    Results
  5. Strata Announces Closing of Revolving Credit Facility to Support
    Update
  6. Strata Critical Medical, Inc. Appoints Will
    Update
  7. Strata Critical Medical Announces Third Quarter 2025 Results
    Results
  8. Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
    Update
  9. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED
    Update
  10. Blade Completes Sale of Passenger
    Update
  11. Blade Air Mobility Announces Second Quarter 2025 Results
    Results
  12. announces sale of Passenger Division to Joby,
    Update
  13. Blade Air Mobility Announces First Quarter 2025 Results
    Results
  14. Blade Air Mobility Announces Fourth Quarter 2024 Results
    Results
  15. Blade Air Mobility Announces Third Quarter 2024 Results
    Results

See a number that looks wrong?